Ta strona używa pliki cookies, w celu polepszenia użyteczności i funkcjonalności oraz w celach statystycznych. Dowiedz się więcej w Polityce prywatności.
Korzystając ze strony wyrażasz zgodę na używanie plików cookies, zgodnie z aktualnymi ustawieniami przeglądarki.
Akceptuję wykorzystanie plików cookies
Health Problems of Civilization
eISSN: 2354-0265
ISSN: 2353-6942
Health Problems of Civilization Physical activity: diseases and issues recognized by the WHO
Current issue Archive Online first About the journal Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Share:
Share:
abstract:
Case report

DIAGNOSTIC CHALLENGES IN THE PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME (PIMS/MIS-C) IN A 6-YEAR-OLD BOY: A CASE REPORT

Alicja Kamińska
1
,
Bartłomiej Żaczek
2
,
Jakub Kozłowski
3
,
Marta Czubaj-Kowal
1, 3
,
Mateusz Heba
3
,
Elżbieta Rychlicka
3
,
Aleksandra Kocjan
4
,
Kamil Marzec
3
,
Wojciech Kupczak
3

  1. Stefan Żeromski Specialist Hospital, Kraków, Poland
  2. University Children's Hospital of Cracow (UCH), Kraków, Poland
  3. Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Kraków, Poland
  4. Ludwik Rydygier Specialist Hospital, Kraków, Poland
Health Prob Civil.
Online publish date: 2025/02/20
View full text Get citation
 
PlumX metrics:
Pediatric Inflammatory Multisystem Syndrome (PIMS), or Multisystem Inflammatory Syndrome in Children (MIS-C), is a severe systemic inflammatory condition in children often occurring after asymptomatic SARS-CoV-2 infection. It is life-threatening, characterized by high fever (>38.5°C), and multisystem inflammation. Symptoms include severe abdominal pain, chest pain, arrhythmias, rash, and conjunctivitis. Laboratory findings typically show elevated inflammatory markers, coagulation abnormalities, and cardiac damage. Treatment involves immunoglobulins, glucocorticoids, and biological medicines to suppress immune hyperactivity, reducing inflammation and protecting organ function. PIMS/MIS-C has gained attention in the post-COVID-19 era, with an incidence of 2-5 cases per 100,000 children globally and 4 per 100,000 in Poland. Early recognition is crucial to mitigate severe outcomes. The report discusses a 6-year-old male presenting with high fever, abdominal pain, and rash, alongside laboratory evidence of inflammation and coagulopathy. Differential diagnoses included Kawasaki disease, septic shock, and toxic shock syndrome. Treatment followed the WHO guidelines, including immunoglobulins, glucocorticoids, and acetylsalicylic acid. Timely intervention prevented complications such as coronary aneurysms and myocardial dysfunction. Continued research and education are essential to enhance diagnostic and therapeutic strategies.
keywords:

MIS-C, SARS-CoV-2, PIMS, inflammation, treatment


Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.

New guidelines for authors!

Starting from 1 January 2025, all authors are obliged to follow new guidelines in “Health Problems of Civilization”.


While preparing the manuscript for submission, authors must follow formatting instructions included

in the Word templates that can be found in the “Instructions for authors” section of our website.

New information about fees!